Researcher

Crijns, H.J.G.M.

HH / A, Vakhoogleraar

View graph of relations
  1. 2018
  2. Published
  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. Published
    Roselli, C., Chaffin, M. D., Weng, L-C., Aeschbacher, S., Ahlberg, G., Albert, C. M., ... Ellinor, P. T. (2018). Multi-ethnic genome-wide association study for atrial fibrillation. Nature Genetics, 50(9), 1225-1233. https://doi.org/10.1038/s41588-018-0133-9
  13. Published
  14. Published
    RACE 3 Investigators, Rienstra, M., Hobbelt, A. H., Alings, M., Tijssen, J. G. P., Smit, M. D., ... Van Gelder, I. C. (2018). Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. European Heart Journal, 39(32), 2987-2996. https://doi.org/10.1093/eurheartj/ehx739
  15. Published
  16. Published
  17. Published
    EORP-AF Gen Pilot Registry Investi, Fumagalli, S., Said, S. A., Laroche, C., Gabbai, D., Boni, S., ... Lip, G. Y. H. (2018). Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. European Heart Journal-Cardiovascular Pharmacotherapy, 4(3), 172-179. https://doi.org/10.1093/ehjcvp/pvx037
  18. Published
  19. Published
  20. Published
  21. Published
  22. Published
  23. Published
  24. Published
  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
    Kotecha, D., Breithardt, G., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., ... Kirchhof, P. (2018). Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Europace, 20(3), 395-407. https://doi.org/10.1093/europace/eux318
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
  37. 2017
  38. Published
  39. Published
    Guerra, F., Brambatti, M., Nieuwlaat, R., Marcucci, M., Dudink, E., Crijns, H. J. G. M., ... Capucci, A. (2017). Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey. Europace, 19(12), 1922-1929. https://doi.org/10.1093/europace/eux205
  40. Published
  41. Published
  42. Published
    Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., ... Hemels, M. E. W. (2017). Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry. Netherlands Heart Journal, 25(10), 551-558. https://doi.org/10.1007/s12471-017-1009-9
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. Published
  49. Published
    Van Gelder, I. C., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., ... Connolly, S. J. (2017). Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. European Heart Journal, 38(17), 1339-1344. https://doi.org/10.1093/eurheartj/ehx042
  50. Published
  51. Published
  52. Published
Previous 1 2 3 4 5 Next